IntroductionRats of WAG/Rij strain are widely used as a model of human absence epilepsy [1]. Recently, we reported that tissue histamine concentrations in a number of brain structures (e.g. in striatum, cortex, pons-medulla) were lower in WAG/Rij rats than in non-epileptic Wistar rats and that H 1 -receptors were denser in several regions of the epileptic rats (e.g. in brainstem nuclei) [2,3]. The purpose of the present study was to find out whether systemic administration of an H 1 -receptor antagonist had any effect on absence seizures in WAG/Rij rats.
Materials and methodsTen male WAG/Rij rats (weight 220-350 g, age 5-7 months) were anaesthetized (chloral hydrate 4% solution, 10 ml/kg i.p; procaine 2% solution for soft tissue) and chronically implanted with epidural electrodes (stainless steel screws). The cortical electrodes were placed over the frontal and parieto-occipital regions of the neocortex with reference electrodes inserted over the cerebellum. Animals were allowed to recover from the surgery at least for 10 days. EEGs were recorded in freely moving animals. An index of epileptic activity, taken as a percentage of time occupied by the generalized spike-wave discharges [4] (spike-wave index, SWI), was calculated for each rat individually from the baseline EEGs recorded for 30-45 min. After i.p. pyrilamine injection (pyrilamine maleate, 20 mg/kg) EEG was monitored for 45-60 min. All experiments were performed according to institutional and national guidelines of animal care.Statistical analysis was performed by Kruskal-Wallis ANOVA and the Wilcoxon matched pairs test. Results are presented as the medians and ranges.
Results and discussionNo general effect of pyrilamine on absence epileptic phenomena was found. Instead, both aggravation (post-injection SWI higher than basal SWI) and reduction (post-injection SWI lower than basal SWI) of the seizure activity were observed. Furthermore, statistical analysis revealed that Inflamm. res. 54, Supplement 1 (2005) S40-S41 increased or decreased epileptic activity after administration of pyrilamine corresponded to low and high basal level of absence seizures in individual rats, respectively (Fig. 1). Rats reacting with increment of absence seizures (N 1 = 5) had basal SWI of 1.5% (range 0.4%-2.4%), whereas the rats reacting with decrement of absence seizures (N 2 = 5) had basal SWI of 7.1% (range 5.4%-12%). The difference in the basal SWI between these two groups was statistically significant (N 1,2 = 5, p = 0.009 according to the Kruskal-Wallis ANOVA by ranks). The treatment effects were also significant (N 1,2 = 5, p = 0.04 for both groups, Wilcoxon matched pairs test). In the rats with low basal SWI (see above) the median SWI increased up to 3.5% (range: 2.4%-8.3%), in the rats with high basal SWI (see above) the median SWI decreased down to 0.6% (range 0%-4.9%).Pyrilamine in the dose of 20 mg/kg has been reported to induce electroencephalographic and behavioural convulsions in non-epileptic rats [5]. In our experiments with WAG/Rij rats no signs of behaviou...